Department of Dermatology, Goztepe Training and Research Hospital, Istanbul, Turkey.
J Eur Acad Dermatol Venereol. 2010 Jul;24(7):840-3. doi: 10.1111/j.1468-3083.2009.03488.x. Epub 2009 Nov 17.
Despite its nature as a systemic vasculitis, renal involvement is known to occur infrequently in Behçet's Disease (BD).
Our aim was to investigate proteinuria, microhematuria and microalbuminuria in 24-h urine and evaluate subclinical or symptomatic renal involvement in BD patients.
Two hundred and eleven patients who fulfilled the International Behçet's Disease criteria were included in the study. After urine analysis, five of 12 patients who were found to have proteinuria underwent renal biopsy, while 199 patients without proteinuria were investigated for microalbuminuria (MA).
A total of 34 (16.1%) patients were found to have renal involvement including 22 (11.1%) with MA and 12 with proteinuria (5.6%). Renal biopsies resulted as focal glomerulosclerosis in three, membranous glomerulosclerosis in one and secondary amyloidosis in two patients. Neurological involvement was found to be significantly more prevalent in patients with MA (P < 0.01). Neurological involvement and duration of disease (> or = 10 years) was found to increase the risk for MA by 21.75-fold and 5.03-fold, respectively. Though age over 40 years, thrombophlebitis, HLA B51 haplotype and ophthalmological involvement were not found to be significantly associated with MA; these parameters increased the risk for MA.
Renal involvement may be more prevalent in BD than it has been recognized; it usually presents with asymptomatic microhematuria, proteinuria and/or microalbuminuria; therefore clinicians must check 24-h urine for the presence of proteinuria, microhematuria and microalbuminuria; especially in patients who are aged over 40 years, have a longer duration of the disease and multisystem involvement.
尽管贝赫切特病(BD)属于系统性血管炎,但肾脏受累并不常见。
本研究旨在调查 24 小时尿液中的蛋白尿、镜下血尿和微量白蛋白尿,并评估 BD 患者的亚临床或有症状的肾脏受累情况。
本研究纳入了 211 名符合国际贝赫切特病标准的患者。在尿液分析后,发现 12 名蛋白尿患者中有 5 名进行了肾活检,而其余 199 名无蛋白尿患者进行了微量白蛋白尿(MA)检查。
共有 34 名(16.1%)患者存在肾脏受累,其中 22 名(11.1%)存在 MA,12 名存在蛋白尿(5.6%)。肾活检结果显示 3 例为局灶性肾小球硬化,1 例为膜性肾小球肾炎,2 例为继发性淀粉样变性。MA 患者的神经系统受累明显更为常见(P < 0.01)。神经系统受累和疾病持续时间(≥10 年)使 MA 的风险分别增加 21.75 倍和 5.03 倍。虽然年龄超过 40 岁、血栓性静脉炎、HLA B51 单倍型和眼部受累与 MA 无显著相关性,但这些参数增加了 MA 的风险。
BD 患者的肾脏受累可能比以往认识到的更为常见;它通常表现为无症状性镜下血尿、蛋白尿和/或微量白蛋白尿;因此,临床医生必须检查 24 小时尿液中是否存在蛋白尿、镜下血尿和微量白蛋白尿;特别是在年龄超过 40 岁、疾病持续时间较长且多系统受累的患者中。